Live Breaking News & Updates on Hans Moebius

Stay updated with breaking news from Hans moebius. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Mark Litton , Sharay Setti , Hans Moebius , Rachel Lenington , Sherif Reda , Athira Pharma , Julie Rathbun , Alzheimer Association International Congress , Motor Neurone Disease Association , Society For Neuroscience Sfn Annual Meeting , Securities Exchange , International Symposium , Exchange Commission , Clinical Development Pipeline Programs , Development Rd Expenses , Athira Pharma Inc , Amyotrophic Lateral Sclerosis Consortium , International Conference On Alzheimer , American Association Of Neurology , Chief Executive Officer , Annual Meeting , Chief Operating Officer , Chief Development Officer , Samantha Willing , International Conference ,

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United States , Deepika Jalota , Adi Hoess , Marc Fellous , Max Bayer , Molly Gibson , Daiichi Sankyo , Hans Moebius , Robert Califf , Paolo Martini , Julie Tierney , Ramin Farzaneh , Adam Perlman , Rob Scott , Celia Lin , Abionyx Pharma , Christi Shaw , Athira Pharma , Tim Kelly , S Michael Rothenberg , Kronos Bio , Dave Licata , Robert Brenner , Miguel Arcinas , Sanofi Genzyme , Kyle Chiang ,

Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

Completed enrollment in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease and expects topline data in second half of 2024 Plans to. ....

United States , Mark Litton , Hans Moebius , Julie Rathbun , Athira Pharma , Securities Exchange , Motor Neurone Disease Association , Exchange Commission , Alzheimer Association International Congress , Athira Pharma Inc , Amyotrophic Lateral Sclerosis Consortium , American Association Of Neurology , Management Team , Chief Executive Officer , Chief Medical Officer , Senior Scientific Advisor , Pipeline Outlook , Label Extension , American Association , Association International Congress , Senior Scientific , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Media Contact ,

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton

Athira Pharma (ATHA) Reports Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark Litton , Hans Moebius , Athira Pharma Inc , Kevin Church , Athira Pharma , Chief Medical Officer , Chief Scientific Officer , Chief Executive Officer ,

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

Exploratory findings add to increasing body of clinical and preclinical data supporting positive modulation of the neurotrophic HGF system as a potential therapeutic approach for neurodegenerative. ....

United States , Athira Pharma , Mark Litton , Julie Rathbun , Hans Moebius , Exchange Commission , Athira Pharma Inc , Kevin Church , Securities Exchange , Chief Medical Officer , Chief Scientific Officer , Chief Executive Officer , Global Statistical Test , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,